Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1.
D-2-hydroxyglutarate
IDH mutation
aloperine
intrahepatic cholangiocarcinoma
quinolizidine alkaloids
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Aug 2024
25 Aug 2024
Historique:
received:
09
07
2024
revised:
18
08
2024
accepted:
19
08
2024
medline:
14
9
2024
pubmed:
14
9
2024
entrez:
14
9
2024
Statut:
epublish
Résumé
Intrahepatic cholangiocarcinoma (ICC) is a universally lethal malignancy with increasing incidence. However, ICC patients receive limited benefits from current drugs; therefore, we must urgently explore new drugs for treating ICC. Quinolizidine alkaloids, as essential active ingredients extracted from
Identifiants
pubmed: 39273177
pii: ijms25179226
doi: 10.3390/ijms25179226
pii:
doi:
Substances chimiques
Isocitrate Dehydrogenase
EC 1.1.1.41
Piperidines
0
Antineoplastic Agents
0
aloperine
56293-29-9
Quinolizidines
0
IDH1 protein, human
EC 1.1.1.42.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Shanxi Key Laboratory of Redevelopment of Famous Local Traditional Chinese Medicines
ID : 202104010910001
Organisme : Natural Science Funding of Shanxi Province
ID : 202203021221010
Organisme : National Natural Science Foundation of China
ID : 82304319
Organisme : the Program of State Key Laboratory of Quantum Optics and Quantum Optics Devices
ID : KF202106
Organisme : the Traditional Chinese Medicine Innovation Team of Shanxi Province
ID : zyytd2024020
Organisme : the Innovation Team of Shandong Higher School Youth Innovation Technology Program
ID : 2022KJ197